Renasant (RNST)
(Delayed Data from NYSE)
$30.54 USD
+0.73 (2.45%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $30.53 -0.01 (-0.03%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$30.54 USD
+0.73 (2.45%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $30.53 -0.01 (-0.03%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth A Momentum C VGM
Zacks News
Renasant (RNST) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Renasant (RNST) delivered earnings and revenue surprises of 3.92% and 7.88%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Renasant (RNST) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Renasant (RNST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Renasant (RNST) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Renasant (RNST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Renasant (RNST) in Focus: Stock Moves 7.8% Higher
by Zacks Equity Research
Renasant (RNST) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Renasant (RNST) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Renasant (RNST) delivered earnings and revenue surprises of 73.33% and 15.05%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Renasant (RNST) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Renasant (RNST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Renasant (RNST) Lags Q1 Earnings Estimates
by Zacks Equity Research
Renasant (RNST) delivered earnings and revenue surprises of -63.64% and 0.33%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Renasant (RNST) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Renasant (RNST) delivered earnings and revenue surprises of -9.33% and -3.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Renasant (RNST) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Renasant (RNST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Renasant (RNST) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Renasant (RNST) delivered earnings and revenue surprises of 1.23% and 0.84%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Renasant (RNST) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Renasant (RNST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Renasant (RNST) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Renasant (RNST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Renasant (RNST) Q1 Earnings Match Estimates
by Zacks Equity Research
Renasant (RNST) delivered earnings and revenue surprises of 0.00% and 0.39%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Renasant (RNST) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Renasant (RNST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Renasant (RNST) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Renasant (RNST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Renasant (RNST) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Renasant (RNST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Renasant (RNST) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Renasant (RNST) delivered earnings and revenue surprises of 4.00% and -0.15%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Renasant (RNST) Q3 Earnings Preview: What to Watch Ahead of the Release
by Zacks Equity Research
Renasant (RNST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Renasant (RNST) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Renasant (RNST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SMART Global Holdings, Natus Medical, Interactive Brokers Group, Renasant and GATX highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
SMART Global Holdings, Natus Medical, Interactive Brokers Group, Renasant and GATX highlighted as Zacks Bull and Bear of the Day
3 Stocks Likely to Beat Earnings Estimates This Week
by Ryan McQueeney
Earnings season is finally heating up, and this week should mark the first truly busy stretch for Q4 reports. Check out these three stocks that are likely to beat earnings estimates this week!
Is a Surprise Coming for Renasant (RNST) This Earnings Season?
by Zacks Equity Research
Renasant (RNST) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Is Renasant a Great Stock for Value Investors?
by Zacks Equity Research
Let's see if Renasant Corporation (RNST) stock is a good choice for value-oriented investors right now from multiple angles.